Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
FIRST QUARTERLY REPORT 2022/2023
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022/2023 First Quarterly Report' and contains detailed unaudited consolidated financial results for the three months ended 30 September 2022. It includes comprehensive financial statements such as profit or loss, other comprehensive income, notes on accounting policies, revenue breakdown, income tax expense, earnings per share, and movement of reserves. The content is substantive and detailed, consistent with a quarterly financial report. The document is not a brief announcement or a certification letter, nor is it a presentation or a regulatory filing. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2022-11-14 English
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2022' and contains detailed unaudited consolidated financial results, including profit and loss statements, notes on accounting policies, revenue breakdown, income tax expense, earnings per share, movement of reserves, and management discussion and analysis. The content includes substantive financial data and analysis for a quarterly period, not just a brief announcement or a link to a report. The document is approximately 15,000 characters long, indicating it is a full report rather than a short announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2022-11-14 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 7 NOVEMBER 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 7 November 2022. It details the voting outcome on a specific resolution related to a Loan Capitalisation Agreement and the transactions contemplated thereunder. The text includes vote counts, percentages, and information about shareholders who abstained from voting. There is no detailed financial data, management discussion, or full report content. The document is not a full report but an official announcement of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5020 characters, which is consistent with an announcement rather than a full report.
2022-11-07 English
POSITIVE PROFIT ALERT
Earnings Release Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement made pursuant to the GEM Listing Rules and Inside Information Provisions. It provides a preliminary profit forecast for the three months ended 30 September 2022 based on unaudited consolidated management accounts. The announcement explicitly states that the final unaudited consolidated results will be announced later and that the current information is a preliminary assessment, not audited or reviewed by auditors. The document length is 4196 characters, which is relatively short and primarily serves as an alert or update rather than a full financial report. It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). Instead, it is a market-sensitive announcement about expected profit results. Such documents are commonly classified as Earnings Releases (ER) because they provide initial key financial highlights for a period, even if preliminary and unaudited. Therefore, the appropriate classification is Earnings Release (ER). Q1 2023
2022-11-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022
Capital/Financing Update Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on authorized and issued shares, share options, convertible bonds, and other related capital changes for Sinopharm Tech Holdings Limited. It includes detailed tables on share capital, share options, convertible bonds, and confirmations related to securities issuance. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is focused on capital structure changes and securities movements rather than financial performance, management changes, or legal matters. It is not an announcement of a report but a substantive regulatory filing detailing share capital movements for a specific month (October 2022). This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, or capital structure changes.
2022-11-03 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a board meeting to approve the unaudited consolidated results for the quarter ended 30 September 2022 and to consider dividend payment. It is a short announcement (2395 characters) that informs about a future event (board meeting) and does not contain actual financial data or detailed financial statements. It is not the financial report itself but a notice related to the timing of financial results approval and publication. According to the rules, such short announcements about meetings or report approvals are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the report itself.
2022-11-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.